When Ozempic Doesn’t Work, Your Body Is Not Failing You

By Dr. Marian Asaad
Clinical Nutrition Specialist

There is a sentence I hear often from people who start GLP-1 medications such as Ozempic or Wegovy: “Why did it work for everyone else, but not for me?”

Behind that question is not only medical frustration. There is also shame, disappointment, and the heavy feeling that the body has somehow betrayed its owner. Many patients begin this journey after years of dieting, restriction, failed attempts, social judgment, and painful comparisons. So when a medication that has changed many lives does not bring the expected result, the emotional impact can be deep.

A recent study led by researchers at Stanford Medicine and published in Genome Medicine offers an important new piece of this puzzle. The researchers found that genetic differences in a gene called PAM may make about 10 percent of people less responsive to GLP-1 based medications, especially when it comes to blood sugar control in type 2 diabetes.

In simpler terms, some bodies may produce GLP-1, but may not respond to it efficiently. Researchers have described this possible pattern as “GLP-1 resistance.”

This matters because it challenges one of the most harmful assumptions placed on patients: that if a treatment does not work, the patient must have done something wrong.

Not every weak response to treatment is a matter of willpower. Not every slow result means poor discipline. Sometimes the body is simply more complex than the quick judgments we make about it.

GLP-1 medications have helped many people improve blood sugar control, reduce appetite, and lose weight. But they are not magic, and they do not work in the same way for every person. The Stanford-led study focused mainly on blood sugar outcomes in people with type 2 diabetes. It did not prove that the same genetic differences fully explain why some people lose less weight on medications such as Ozempic or Wegovy.

That distinction is important. We should not turn early scientific findings into dramatic headlines or false promises. Response to treatment can be affected by many factors, including genetics, dosage, treatment duration, age, sleep, stress, insulin resistance, nutrition patterns, physical activity, other medications, and overall health.

From a clinical nutrition perspective, this research reminds us that medication may be an important tool, but it is never the whole story. Food choices, medical follow-up, emotional health, sleep, stress, and a realistic long-term plan still matter. The patient is not a number on a scale, a blood test result, or a before-and-after photo. The patient is a human being with a history, fears, pressures, habits, hopes, and often a complicated relationship with food and body image.

The hopeful part of this discovery is that it may help medicine become more personal and more fair. One day, doctors may be able to better identify who is likely to respond well to a certain treatment and who may need a different plan from the beginning. That is the promise of precision medicine: not treating every body as if it were the same, and not judging every patient by the same result.

My message to anyone who has not seen the result they expected from these medications is simple: do not blame yourself. Do not stop or change your medication without speaking to your doctor, but do have an honest conversation. Ask about your options. Ask whether the dose, timing, nutrition plan, medical history, or other factors may be affecting your response. Ask for a plan that fits your body, not someone else’s experience.

And to those who comment on other people’s bodies or treatment choices, please be kinder. Not everyone who struggles with weight lacks discipline. Not everyone who needs medication has failed. Not everyone who does not respond quickly is doing something wrong.

The human body is deeper than our assumptions. Real healing begins when science and compassion work together.

Ozempic may not work the same way for everyone. But that does not mean hope is gone. Sometimes the most important scientific discovery is not only a new drug or a new gene, but a new reason to look at patients with more understanding and less judgment.